SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997; 336: 31723.
  • 2
    Olavarria E, Kanfer E, Szydlo R, Kaeda J, Rezvani K, Cwynarski K, Pocock C, Dazzi F, Craddock C, Apperley JF, Cross NC, Goldman JM. Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2001; 97: 15605.
  • 3
    Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG. Failure of immunologic purging in mantle cell lymphoma assessed reaction detection of minimal residual disease. Blood 1997; 15: 421221.
  • 4
    Davies FE, Forsyth PD, Rawstron AC, Owen RG, Pratt G, Evans PA, Richards SJ, Drayson M, Smith GM, Selby PJ, Child JA, Morgan GJ. The impact of attaining a minimal disease state after high-dose autologous transplantation for multiple myeloma. Br J Haematol 2001; 112: 8149.
  • 5
    Liefers GJ, Tollenaar RAEM. Cancer genetics and their application to individualised medicine. Eur J Cancer 2002; 38: 8729.
  • 6
    Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340: 6859.
  • 7
    Pantel K, Von Knebel Doeberitz M. Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 2000; 12: 95101.
  • 8
    Soeth E, Röder C, Juhl H, Kremer B, Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996; 69: 27882.
  • 9
    Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57: 310610.
  • 10
    Denis MG, Lipart C, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, Lustenberger P. Detection of dissiminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997; 74: 5404.
  • 11
    Wyld DK, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J, Burchill SA. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998; 79: 28893.
  • 12
    Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, Von Knebel Doeberitz M. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 1998; 4: 3438.
  • 13
    Futamura M, Takagi Y, Koumura H, Kida H, Tanemura K, Saji S. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998; 68: 3440.
  • 14
    Wharton RQ, Jonas SK, Glover C, Khan ZAJ, Klokouzas A, Quinn H, Henry M, Allen-Mersh TG. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 1999; 5: 415863.
  • 15
    Kufer P, Zippelius A, Lutterbüse R, Mecklenburg I, Enzmann T, Montag A, Weckermann D, Passlick B, Prang N, Reichardt P, Dugas M, Köllermann MW, Pantel K, Riethmüller G. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease. Cancer Res 2002; 62: 25161.
  • 16
    Bustin SA, Gyselman VG, Williams NS, Dorudo S. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999; 79: 181320.
  • 17
    Jonas S, Windeatt S, O-Boateng A, Allen-Mersh TG. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 1996; 39: 71721.
  • 18
    Zippelius A, Kufer P, Honold G, Köllermann MW, Oberneder R, Schlimok G, Riethmüller G, Pantel K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 1997; 15: 27018.
  • 19
    Ko Y, Klinz M, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 1998; 4: 21416.
  • 20
    Jung R, Krüger W, Hosch S, Holweg M, Kröger N, Gutensohn K, Wagener C, Neumaier M, Zander AR. Specifity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 1998; 78: 11948.
  • 21
    Freeman WM, Walker J, Vrana KE. Quantitative RT-PCR: pitfalls and potential. BioTechniques 1999; 26: 11225.
  • 22
    Dimmler A, Gerhards R, Betz C, Günther K, Reingruber B, Horbach T, Baumann I, Kirchner T, Hohenberger W, Papadopoulos T. Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells. Lab Invest 2001; 81: 135161.
  • 23
    Max N, Willhauck M, Wolf K, Thilo F, Reinhold U, Pawlita M, Thiel E, Keilholz U. Reliability of PCR-based detection of occult tumour cells: lessons from real-time RT-PCR. Melanoma Res 2001; 11: 18.
  • 24
    Bustin S, Dorudi S. Molecular assessment of tumor stage and disease recurrence using PCR-based assays. Mol Med Today 1998; 4: 38996.
  • 25
    Straub B, Müller M, Krause H, Schrader M, Goessl C, Heicappel R, Miller K. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using “light-cycler”-based quantitative real-time polymerase chain reaction. Urology 2001; 58: 81520.
  • 26
    Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12: 7259.
  • 27
    Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55: 341720.
  • 28
    Mori M, Mimori K, Ueo H, Karmine N, Barnard GF, Sugimachi K, Akiyoshi T. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996; 68: 73943.
  • 29
    Castells A, Boix L, Bessa X, Gargallo L, Piqué JM. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998; 78: 136872.
  • 30
    Chausovsky G, Luchansky M, Figer A, Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S, Klein A. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer 1999; 86: 2398405.
  • 31
    Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71: 27881.
  • 32
    Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, Moss P, Paeper B, Wang K. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 2000; 257: 11930.
  • 33
    Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H, Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta 1997; 1350: 114.
  • 34
    Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 1996; 2: 62436.
  • 35
    Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of Zyme/Protease M/Neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics 1999; 62:– 2519.
  • 36
    Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 1569.
  • 37
    Soong R, Beyser K, Basten O, Kalbe A, Rueschoff J, Tabiti K. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin Cancer Res 2001; 7: 34239.
  • 38
    Zippelius A, Pantel K. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors: an overview. Ann NY Acad Sci 2000; 906: 11023.
  • 39
    Ghossein RA, Bhattacharya S. Molecular detection and characterization of circulating tumor cells and micrometastases in solid tumours. Eur J Cancer 2000; 36: 168194.
  • 40
    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analysis and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 2001; 61: 252332.
  • 41
    Van Eekelen JAM, Shammas FV, Wee L, Heikkilä R, Osland A. Quantitative analysis of cytokeratin 20 gene expression using RT-PCR and capillary electrophoresis with fluorescent DNA detection. Clin Biochem 2000; 33: 45764.
  • 42
    Vlems F, Soong R, Diepstra H, Punt C, Wobbes T, Tabiti K, Van Muijen G. Effect of blood sample handling and reverse transcriptase-polymerase chain reaction assay sensitivity on the detection of CK20 expression in healthy donor blood. Diagn Mol Pathol 2002; 11: 907.
  • 43
    Champelovier P, Mongelard F, Seigneurin D. CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 1999; 19: 20738.
  • 44
    Keilholz U, Willhauck M, Rimoldi D, Brasseur F, Dummer W, Rass K, De Vries T, Blaheta J, Voit C, Lethé B, Burchill S. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group. Eur J Cancer 1998; 34: 7503.
  • 45
    Krüger W, Jung R, Kröger N, Gutensohn K, Fiedler W, Neumaier M, Jänicke F, Wagner C, Zander AR. Sensitivity of assays designed for the detection of disseminated epithelial tumor cells is influenced by cell separation methods. Clin Chem 2000; 46: 4356.
  • 46
    Park S, Lee B, Kim I, Choi I, Hong K, Ryu Y, Shin J, Park SC, Chung H, Chung J. Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. J Cancer Res Clin Oncol 2001; 127: 48994.
  • 47
    Hardingham JE, Hewett PJ, Sage RE, Finch JL, Nutall JD, Kotasek D, Dobrovic A. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 2000; 89: 813.
  • 48
    Zhong XY, Kaul S, Lin YS, Eichler A, Bastert G. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19. J Cancer Res Clin Oncol 2000; 126: 2128.
  • 49
    Ito S, Nakanishi H, Hirai T, Kato T, Kodera Y, Feng Z, Kasai Y, Ito K, Akiyama S, Nakao A, Tatematsu M. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 2002; 183: 195203.
  • 50
    Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998; 95: 458994.
  • 51
    Ueda T, Furui J, Komuta K, Yamaguchi J, Yamamoto M, Furukawa K, Kanematsu T. Detection of carcinoembryonic antigen mRNA in the mesenteric vein of patients with resectable colorectal cancer. Surg Today 1998; 28: 7016.
  • 52
    Litle VR, Warren RS, More D, Pallavicini MG. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer 1997; 79: 166470.
  • 53
    Koch M, Weitz J, Kienle P, Benner A, Willeke F, Lehnert T, Herfarth C, Von Knebel Doeberitz M. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 2001; 136: 859.
  • 54
    Weitz J, Kienle P, Magener A, Koch M, Schrödel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth CV. Knebel Doeberitz M. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999; 5: 18306.
  • 55
    Patel H, Le Marer N, Wharton RQ, Khan ZAJ, Araia R, Glover C, Henry MM, Allen-Mersh TG. Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 2002; 235: 22631.